8-K: VSee Health Invests in GoMyRx, Secures Services Deal

VSee Health, Inc. announced a strategic investment of $2.0 million for a 10% stake in digital prescription platform GoMyRx, alongside a managed services agreement.

Summary

• VSee Health, Inc. (VSee) and its wholly-owned subsidiary, iDoc Virtual Telehealth Solutions, Inc., entered into a Managed Services Agreement (MSA) with GoMyRx, Inc. (GMRx) on December 26, 2025.
• Under the MSA, VSee will provide GMRx with platform administration, customer and user support, third-party vendor coordination, and reporting/governance services.
• VSee will invoice GMRx monthly for actual expenses incurred in performing the services, plus an additional ten percent (10%).
• The MSA has a term expiring on December 26, 2027, with an option for either party to extend it on a month-to-month basis for an additional six months.
• GMRx retains the right to terminate the MSA at any time with twenty (20) days written notice to VSee.
• On January 16, 2026, VSee entered into a Stock Purchase Agreement (SPA) to acquire $2.0 million of GMRx's common stock from Go Biz Holdings, LLC.
• This acquisition represents a ten percent (10%) ownership interest in GMRx.
• The stock purchase was a private transaction, exempt from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506 of Regulation D.
• The acquired shares bear a restrictive legend, limiting their sale or transfer without compliance with securities laws.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive strategic move, expanding VSee's market reach and revenue potential through both investment and service provision in a growing sector, despite the associated capital outlay and termination clause.

Positives

• VSee Health is expanding its strategic footprint by investing in a digital prescription fulfillment platform, GoMyRx, which aligns with broader telehealth trends.
• The Managed Services Agreement provides a new revenue stream for VSee, based on actual expenses plus a 10% margin, indicating a profitable service offering.
• The 10% ownership stake in GoMyRx offers VSee potential for capital appreciation and strategic influence within the digital pharmacy sector.
• The agreements position VSee to offer a more integrated healthcare ecosystem, potentially enhancing its value proposition to customers.

Negatives

• The $2.0 million investment in GoMyRx represents a significant capital outlay for VSee.
• GoMyRx has the right to terminate the Managed Services Agreement with VSee on 20 days' written notice, introducing a degree of revenue uncertainty for the services provided.
• The shares acquired in GoMyRx are subject to a restrictive legend, limiting liquidity and transferability.

Risks

• GMRx's right to terminate the Managed Services Agreement with 20 days' notice poses a risk to VSee's anticipated service revenue.
• The investment in GMRx's common stock carries inherent equity investment risks, including the potential for loss of capital if GMRx's business performance declines.
• The restrictive legend on the acquired shares means VSee cannot easily sell or transfer its 10% ownership in GMRx without complying with specific securities laws, potentially limiting liquidity.

Future Outlook

The Managed Services Agreement is set for a two-year term with an option for a six-month extension, indicating VSee's intent for a sustained operational relationship. The strategic investment in GoMyRx suggests VSee anticipates growth and synergy within the digital prescription fulfillment market.

Management Comments

• Imoigele Aisiku, Co-Chief Executive Officer of VSee Health, Inc., signed the 8-K filing, indicating management's formal approval and commitment to these strategic agreements.
• The agreements reflect VSee's strategy to expand its service offerings and integrate with complementary healthcare platforms.

Industry Context

StockSavvy.ai notes this move aligns with the broader industry trend of telehealth providers expanding their ecosystems to include adjacent services like digital pharmacy and prescription fulfillment. By investing in GoMyRx and providing managed services, VSee Health is positioning itself to offer a more comprehensive and integrated digital healthcare solution, potentially enhancing patient engagement and capturing a larger share of the evolving digital health market.

Related Party Transactions

• VSee Health, Inc. entered into a Managed Services Agreement with GoMyRx, Inc., an affiliate company of the GoMyDocs healthcare ecosystem.
• VSee Health, Inc. acquired a 10% ownership interest in GoMyRx, Inc., making GoMyRx an affiliate and the transactions related party dealings.

Stakeholder Impact

• Shareholders: Potential for increased revenue, strategic growth, and diversification into the digital prescription market, but also a $2.0 million capital deployment.
• Customers: Potential for a more integrated and comprehensive telehealth and prescription fulfillment experience.
• Employees: Potential for new operational responsibilities related to providing managed services to GoMyRx.

Next Steps

• VSee Health, Inc. will commence providing managed services to GoMyRx, Inc. as per the agreement.
• VSee Health, Inc. will integrate GoMyRx into its strategic operations as a 10% owner.
• The Managed Services Agreement will continue until its termination date of December 26, 2027, unless extended or terminated earlier by GMRx.

Key Dates

Recommendation

The strategic investment and managed services agreement position VSee Health for growth in the expanding digital health and prescription fulfillment market. This move offers potential for diversified revenue streams and ecosystem expansion, which could drive long-term shareholder value.

Keywords

Telehealth, Digital Health, Managed Services, Strategic Investment, Prescription Fulfillment, Healthcare Technology, SEC Filing, VSee Health, GoMyRx